{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:06:53Z","timestamp":1780517213642,"version":"3.54.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cpet.2026.02.006","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:20:06Z","timestamp":1778098806000},"page":"331-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Theranostics in Nuclear Medicine"],"prefix":"10.1016","volume":"21","author":[{"given":"Deepak","family":"Behera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"McEwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.cpet.2026.02.006_bib4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1001\/jama.1946.02870490016004","article-title":"Radioactive iodine therapy: effect on functioning metastases of adenocarcinoma of the thyroid","volume":"132","author":"Seidlin","year":"1946","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.cpet.2026.02.006_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7326\/0003-4819-37-1-23","article-title":"Indication and contraindications for treatment of thyroid cancer with radioactive iodine","volume":"37","author":"Beierwaltes","year":"1952","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.cpet.2026.02.006_bib6","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.7150\/thno.96675","article-title":"Theranostics - a sure cure for cancer after 100 years?","volume":"14","author":"Song","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.cpet.2026.02.006_bib8","doi-asserted-by":"crossref","unstructured":"Pascual TNB, Paez D, Iagaru A, et al. Guiding principles on the education and practice of theranostics. Eur J Nucl Med Mol Imaging. 2024;51(8):2320-2331. Erratum in: Eur J Nucl Med Mol Imaging. 2025 Nov;52(13):5209-5210. https:\/\/doi.org\/10.1007\/s00259-025-07369-x.","DOI":"10.1007\/s00259-025-07369-x"},{"key":"10.1016\/j.cpet.2026.02.006_bib9","doi-asserted-by":"crossref","unstructured":"Scott AM, Zeglis BM, Lapi SE, et al. Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics. Lancet Oncol. 2024;25(6):e250-e259. Erratum in: Lancet Oncol. 2024 Aug;25(8):e336. https:\/\/doi.org\/10.1016\/S1470-2045(24)00378-4.","DOI":"10.1016\/S1470-2045(24)00037-8"},{"issue":"2","key":"10.1016\/j.cpet.2026.02.006_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-Dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.cpet.2026.02.006_bib13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","article-title":"VISION Investigators. Lutetium-177\u2013PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.cpet.2026.02.006_bib14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000337634","article-title":"Radionuclide therapy of bone metastases","volume":"7","author":"Fischer","year":"2012","journal-title":"Breast Care (Basel)"},{"issue":"18","key":"10.1016\/j.cpet.2026.02.006_bib15","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","article-title":"Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer","volume":"366","author":"Mallick","year":"2012","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.cpet.2026.02.006_bib16","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","article-title":"Strategies of radioiodine ablation in patients with low-risk thyroid cancer","volume":"366","author":"Schlumberger","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.cpet.2026.02.006_bib17","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2967\/jnumed.111.100123","article-title":"MIRD pamphlet no. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy","volume":"53","author":"Dewaraja","year":"2012","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2026.02.006_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2967\/jnumed.115.159012","article-title":"MIRD pamphlet no. 26: joint EANM\/MIRD guidelines for quantitative 177Lu SPECT applied for dosimetry of radiopharmaceutical therapy","volume":"57","author":"Ljungberg","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.02.006_bib19","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00259-022-05727-7","article-title":"EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands","volume":"49","author":"Sj\u00f6green Gleisner","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2026.02.006_bib31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ijrobp.2025.09.028","article-title":"Industry sponsorship and disease site focus in therapeutic radiopharmaceutical clinical trials over the past decade","volume":"124","author":"Howell","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cpet.2026.02.006_bib32","article-title":"An overview of current phase 3 radiopharmaceutical therapy clinical trials","volume":"12","author":"Lepareur","year":"2025","journal-title":"Front Med (Lausanne)"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826000246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826000246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:40:27Z","timestamp":1780515627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859826000246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1556859826000246"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2026.02.006","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Theranostics in Nuclear Medicine","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2026.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}